Stockscreener 앱 받기
0.3508
0.26%
0.0009
시간 외 거래:
.35
-0.0008
-0.23%
전일 마감가:
$0.3499
열려 있는:
$0.34
하루 거래량:
3.60M
Relative Volume:
2.09
시가총액:
$5.34M
수익:
$486.00K
순이익/손실:
$-28.43M
주가수익비율:
-0.1244
EPS:
-2.8189
순현금흐름:
$-26.75M
1주 성능:
-1.71%
1개월 성능:
-72.81%
6개월 성능:
-85.80%
1년 성능:
-81.14%
1일 변동 폭
$0.332
$0.3979
1주일 범위
$0.33
$0.3979
52주 변동 폭
$0.33
$4.30
Vyne Therapeutics Inc Stock (VYNE) Company Profile
명칭
Vyne Therapeutics Inc
전화
800-775-7936
주소
685 ROUTE 202/206 N., SUITE 301, BRIDGEWATER
VYNE을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VYNE
Vyne Therapeutics Inc
|
0.3508 | 5.83M | 486.00K | -28.43M | -26.75M | -2.8189 |
|
VRTX
Vertex Pharmaceuticals Inc
|
392.79 | 100.07B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.41 | 59.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
448.91 | 58.03B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
653.83 | 39.93B | 3.06B | 1.28B | -614.78M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
321.36 | 36.82B | 3.81B | -644.79M | -669.77M | -6.24 |
Vyne Therapeutics Inc Stock (VYNE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-31 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2024-11-18 | 개시 | BTIG Research | Buy |
| 2021-12-06 | 재개 | H.C. Wainwright | Buy |
Vyne Therapeutics Inc 주식(VYNE)의 최신 뉴스
Is VYNE Therapeutics Inc. stock poised for growth2025 Trade Ideas & Fast Gain Swing Alerts - Newser
Tools to assess VYNE Therapeutics Inc.’s risk profileDay Trade & Expert Approved Trade Ideas - Newser
How Resilient Is VYNE Therapeutics Inc. Stock During Economic DownturnsTake Profit & Fast Entry High Yield Tips - Newser
Price action breakdown for VYNE Therapeutics Inc.July 2025 Recap & Advanced Technical Signal Analysis - Newser
VYNE Therapeutics Inc. (NASDAQ:VYNE) Short Interest Up 526.7% in July - Defense World
Is VYNE Therapeutics Inc. reversing from oversold territory2025 Volatility Report & Weekly Top Gainers Trade List - Newser
Is VYNE Therapeutics Inc. stock entering bullish territoryJuly 2025 Trade Ideas & Safe Capital Growth Stock Tips - Newser
Risk vs reward if holding onto VYNE Therapeutics Inc.Market Weekly Review & Daily Volume Surge Signals - Newser
VYNE Therapeutics Inc. (VYNE) Reports Q2 Loss, Lags Revenue Estimates - MSN
VYNE Stock Update: VYNE Therapeutics Inc’s Banking’s Market Struggles and Potential Opportunities - investchronicle.com
VYNE 2025 Q2 Earnings Losses Narrow Despite Sharp Revenue Drop - AInvest
VYNE Therapeutics Reports Q2 2025 Financials and Updates - TipRanks
Will breakout in VYNE Therapeutics Inc. lead to full recoveryEntry Point & Verified Momentum Watchlists - Newser
Vitiligo Clinical Trial Pipeline Accelerates as 18+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight - GlobeNewswire Inc.
VYNE Therapeutics Reports 2025 Second Quarter Financial Results and Provides Business Update | VYNE Stock News - GuruFocus
VYNE (VYNE) reports quarter results; two directors resign - Stock Titan
VYNE Therapeutics Reports 2025 Second Quarter Financial Results and Provides Business Update - MarketScreener
VYNE's Psoriasis Drug Shows Promise as FDA Partially Lifts Clinical Hold, Cash Position Strengthens - Stock Titan
Does VYNE Therapeutics Inc. stock pay reliable dividendsRecession Risk & AI Based Trade Execution Alerts - Newser
Is VYNE Therapeutics Inc. trending in predictive chart modelsConservative Investment Setup and Risk Analysis - Newser
Volume Surge May Signal Institutional Interest in VYNE Therapeutics Inc.Breakout Confirmation With Entry Tracker Enabled - 선데이타임즈
Technical analysis overview for VYNE Therapeutics Inc. stockSector Rotation and Stock Opportunity Analysis - Newser
What makes VYNE Therapeutics Inc. stock price move sharplyStrong ROI Equity Ideas - thegnnews.com
Aquestive Therapeutics Q2 Earnings Miss Estimates, Revenue Down 50% YoY - AInvest
VYNE Therapeutics (VYNE) Projected to Post Quarterly Earnings on Wednesday - Defense World
Does VYNE Therapeutics Inc. show high probability of reboundTechnical Trade Plan with Entry Checklist - Newser
Will earnings trigger a reversal in VYNE Therapeutics Inc.Free Weekly Hot Picks With Buy Confidence - Newser
A Quick Look at Today's Ratings for VYNE Therapeutics(VYNE.US), With a Forecast Between $2 to $2 - 富途牛牛
Vyne Therapeutics Inc expected to post a loss of 22 cents a shareEarnings Preview - TradingView
How to read the order book for VYNE Therapeutics Inc.Equity Performance Forecast Based on AI Models - Newser
Chart based exit strategy for VYNE Therapeutics Inc.Earnings Impact and Stock Reaction Analysis - Newser
Vyne Therapeutics Inc (VYNE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.41%
0.88%
자본화:
|
볼륨(24시간):